Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/77111
Title: Characterization of sarcomeric protein changes during mouse heart failure progression
Authors: Lam, Do Thuy Uyen Ha
Keywords: DRNTU::Science::Medicine
Issue Date: 2019
Abstract: Cardiovascular disease, especially heart failure and its most common cause – myocardial infarction (MI), is the leading cause of morbidity and mortality. Following an MI event, the heart undergoes extensive remodelling where there is modification to the proteins especially the sarcomeric proteins responsible for the contractility function in cardiomyocytes. Although extensive studies have been done to elucidate the function of these proteins and their post-translational modifications (PTMs), little is known about the changes in expression and PTMs of these proteins during post- MI progression. In this study, we employed a mouse model of surgically-induced MI and two-dimensional gel electrophoresis to examine the changes in protein expression and phosphorylation level (the most prominent PTMs for sarcomeric proteins) following MI. We observed qualitatively an increase in tropomyosin dephosphorylation between day 10 and day 14 post-MI, quantitatively an elevated phosphorylation in myosin regulatory light chain at day 10 followed by its decrease to normal level at day 14. We also noticed a degradation of myosin binding protein C at both time-points. We conclude that following MI, sarcomeric proteins have their own timelines in adaptation to heart failure phenotype to maintain the myocyte contractility. It is unknown whether there is interaction between these timelines.
URI: http://hdl.handle.net/10356/77111
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
FYP Report_Ha_Final.pdf
  Restricted Access
3.07 MBAdobe PDFView/Open

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.